A carregar...

Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer

Until recently, the treatment of patients with advanced non-small-cell lung cancer (NSCLC) whose tumors did not have a targetable genetic alteration was cytotoxic chemotherapy alone. This treatment provided only modest survival benefit. The introduction of immune checkpoint inhibitors targeting prog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Lung Cancer (Auckl)
Main Authors: Weinberg, Frank, Gadgeel, Shirish
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556538/
https://ncbi.nlm.nih.gov/pubmed/31239797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S176391
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!